CYP2C19 progress curve analysis and mechanism-based inactivation by three methylenedioxyphenyl compounds.
Salminen KA, Meyer A, Imming P, Raunio H.
Drug Metab Dispos · research support, non-u.s. gov't; journal article · DOI 10.1124/dmd.111.041319 PUBLICATION REGISTRY
Go to research.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för bulbocapnine. Visa hela publikationsregistret
A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publications in the selection
7 hitsAlkaloidal variation in cissampelos capensis (Menispermaceae).
de Wet H, van Heerden FR, van Wyk BE.
Molecules · research support, non-u.s. gov't; research-article; journal article · DOI 10.3390/molecules16043001Inhibitory effects of bulbocapnine on dopamine biosynthesis in PC12 cells.
Shin JS, Kim KT, Lee MK.
Neurosci Lett · research support, non-u.s. gov't; journal article · DOI 10.1016/s0304-3940(98)00148-7Inhibition of tyrosine hydroxylase by bulbocapnine.
Zhang YH, Shin JS, Lee SS, Kim SH, Lee MK.
Planta Med · letter; research support, non-u.s. gov't · DOI 10.1055/s-2006-957702Major alkaloids of Glaucium flavum Grantz, population Ghom.
Lalezari I, Shafiee A, Mahjour M.
J Pharm Sci · journal article · DOI 10.1002/jps.2600650633Effect of bulbocapnine as a peripheral dopamine receptor antagonists in the anesthetized cat.
Pendleton RG, Finlay E, Sherman S.
Naunyn Schmiedebergs Arch Pharmacol · journal article · DOI 10.1007/bf00501304Inhibition of diamine oxidase by bulbocapnine.
CHAPMAN JE, WALASZEK EJ.
Biochem Pharmacol · journal article · DOI 10.1016/0006-2952(62)90075-8